PEDIATRICS Vol. 7 No. 1 January 1951, pp. 48-52
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BARYSH, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BARYSH, N.

USE OF THE PERTUSSIS AGGLUTINOGEN SKIN TEST IN A WELL BABY CLINIC

NOAH BARYSH M.D.1

1 The A. Jacobi Division for Children of the Lenox Hill Hospital, New York City.

Intradermal skin tests with pertussis agglutinogen were performed on 234 infants.

In one group of 100 infants skin tested with this material, at least three months after pertussis prophylaxis, it was found that 92% had positive (immune) skin reactions.

In a second group of 134 infants skin tested prior to pertussis vaccination, 83% (111) had negative skin reactions. In 66 of these 111 infants tested after pertussis prophylaxis, 92% developed a positive skin response.

The pertussis skin agglutinogen test can be used to determine the efficiency of materials used for pertussis prophylaxis.

The pertussis skin agglutinogen test is a reliable indicator of the immune response of an infant to H. pertussis immunization and is recommended as an effective agent for determining the susceptible infant—one lacking the minimal clinical protection against pertussis—after pertussis vaccination.

Submitted on July 4, 1950